Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Long-term cardiovascular effects of vandetanib and pazopanib in normotensive rats.

Cooper SL, Carter JJ, March J, Woolard J.

Pharmacol Res Perspect. 2019 May 31;7(3):e00477. doi: 10.1002/prp2.477. eCollection 2019 Jun.

2.

Comparison of the ligand-binding properties of fluorescent VEGF-A isoforms to VEGF receptor 2 in living cells and membrane preparations using NanoBRET.

Peach CJ, Kilpatrick LE, Woolard J, Hill SJ.

Br J Pharmacol. 2019 Sep;176(17):3220-3235. doi: 10.1111/bph.14755. Epub 2019 Jul 15.

PMID:
31162634
3.

Complex Formation between VEGFR2 and the β2-Adrenoceptor.

Kilpatrick LE, Alcobia DC, White CW, Peach CJ, Glenn JR, Zimmerman K, Kondrashov A, Pfleger KDG, Ohana RF, Robers MB, Wood KV, Sloan EK, Woolard J, Hill SJ.

Cell Chem Biol. 2019 Jun 20;26(6):830-841.e9. doi: 10.1016/j.chembiol.2019.02.014. Epub 2019 Apr 4.

4.

Probe dependence of allosteric enhancers on the binding affinity of adenosine A1 -receptor agonists at rat and human A1 -receptors measured using NanoBRET.

Cooper SL, Soave M, Jörg M, Scammells PJ, Woolard J, Hill SJ.

Br J Pharmacol. 2019 Apr;176(7):864-878. doi: 10.1111/bph.14575. Epub 2019 Mar 6.

5.

Visualizing Ligand Binding to a GPCR In Vivo Using NanoBRET.

Alcobia DC, Ziegler AI, Kondrashov A, Comeo E, Mistry S, Kellam B, Chang A, Woolard J, Hill SJ, Sloan EK.

iScience. 2018 Aug 31;6:280-288. doi: 10.1016/j.isci.2018.08.006. Epub 2018 Aug 11.

6.

Real-Time Ligand Binding of Fluorescent VEGF-A Isoforms that Discriminate between VEGFR2 and NRP1 in Living Cells.

Peach CJ, Kilpatrick LE, Friedman-Ohana R, Zimmerman K, Robers MB, Wood KV, Woolard J, Hill SJ.

Cell Chem Biol. 2018 Oct 18;25(10):1208-1218.e5. doi: 10.1016/j.chembiol.2018.06.012. Epub 2018 Jul 26.

7.

Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2.

Peach CJ, Mignone VW, Arruda MA, Alcobia DC, Hill SJ, Kilpatrick LE, Woolard J.

Int J Mol Sci. 2018 Apr 23;19(4). pii: E1264. doi: 10.3390/ijms19041264. Review.

8.
9.

Novel selective β1-adrenoceptor antagonists for concomitant cardiovascular and respiratory disease.

Baker JG, Gardiner SM, Woolard J, Fromont C, Jadhav GP, Mistry SN, Thompson KSJ, Kellam B, Hill SJ, Fischer PM.

FASEB J. 2017 Jul;31(7):3150-3166. doi: 10.1096/fj.201601305R. Epub 2017 Apr 11.

10.

Real-time analysis of the binding of fluorescent VEGF165a to VEGFR2 in living cells: Effect of receptor tyrosine kinase inhibitors and fate of internalized agonist-receptor complexes.

Kilpatrick LE, Friedman-Ohana R, Alcobia DC, Riching K, Peach CJ, Wheal AJ, Briddon SJ, Robers MB, Zimmerman K, Machleidt T, Wood KV, Woolard J, Hill SJ.

Biochem Pharmacol. 2017 Jul 15;136:62-75. doi: 10.1016/j.bcp.2017.04.006. Epub 2017 Apr 7.

11.

Effects of 4 multitargeted receptor tyrosine kinase inhibitors on regional hemodynamics in conscious, freely moving rats.

Carter JJ, Fretwell LV, Woolard J.

FASEB J. 2017 Mar;31(3):1193-1203. doi: 10.1096/fj.201600749R. Epub 2016 Dec 16.

12.
13.

Power, Process, and Protection: Juveniles as Defendants in the Justice System.

Woolard JL, Henning K, Fountain E.

Adv Child Dev Behav. 2016;51:171-201. doi: 10.1016/bs.acdb.2016.04.002. Epub 2016 Jun 22. Review.

PMID:
27474426
14.
15.

A Perspective on Studying G-Protein-Coupled Receptor Signaling with Resonance Energy Transfer Biosensors in Living Organisms.

van Unen J, Woolard J, Rinken A, Hoffmann C, Hill SJ, Goedhart J, Bruchas MR, Bouvier M, Adjobo-Hermans MJ.

Mol Pharmacol. 2015 Sep;88(3):589-95. doi: 10.1124/mol.115.098897. Epub 2015 May 13. Review.

16.

Effects of receptor tyrosine kinase inhibitors on VEGF165 a- and VEGF165 b-stimulated gene transcription in HEK-293 cells expressing human VEGFR2.

Carter JJ, Wheal AJ, Hill SJ, Woolard J.

Br J Pharmacol. 2015 Jun;172(12):3141-50. doi: 10.1111/bph.13116. Epub 2015 Apr 10.

17.

Impacts from control operations on a recreationally hunted feral swine population at a large military installation in Florida.

Engeman R, Hershberger T, Orzell S, Felix R, Killian G, Woolard J, Cornman J, Romano D, Huddleston C, Zimmerman P, Barre C, Tillman E, Avery M.

Environ Sci Pollut Res Int. 2014 Jun;21(12):7689-97. doi: 10.1007/s11356-014-2727-9. Epub 2014 Mar 14.

PMID:
24622991
18.

Monoclonal anti-β1-adrenergic receptor antibodies activate G protein signaling in the absence of β-arrestin recruitment.

Hutchings CJ, Cseke G, Osborne G, Woolard J, Zhukov A, Koglin M, Jazayeri A, Pandya-Pathak J, Langmead CJ, Hill SJ, Weir M, Marshall FH.

MAbs. 2014 Jan-Feb;6(1):246-61.

19.

Allosteric interactions at adenosine A(1) and A(3) receptors: new insights into the role of small molecules and receptor dimerization.

Hill SJ, May LT, Kellam B, Woolard J.

Br J Pharmacol. 2014 Mar;171(5):1102-13. doi: 10.1111/bph.12345. Review.

20.

Cardiovascular responses to retigabine in conscious rats--under normotensive and hypertensive conditions.

Fretwell LV, Woolard J.

Br J Pharmacol. 2013 Jul;169(6):1279-89. doi: 10.1111/bph.12203.

21.

Borrelidin modulates the alternative splicing of VEGF in favour of anti-angiogenic isoforms.

Woolard J, Vousden W, Moss SJ, Krishnakumar A, Gammons MV, Nowak DG, Dixon N, Micklefield J, Spannhoff A, Bedford MT, Gregory MA, Martin CJ, Leadlay PF, Zhang MQ, Harper SJ, Bates DO, Wilkinson B.

Chem Sci. 2011 Feb 1;2011(2):273-278.

22.

Changes critical to persistent lowering of arterial pressure in spontaneously hypertensive rat occur early in antihypertensive treatment.

Hale TM, Bushfield TL, Woolard J, Pang JJ, Rees-Milton KJ, Adams MA.

J Hypertens. 2011 Jan;29(1):113-22. doi: 10.1097/HJH.0b013e32833fb7cb.

PMID:
20871411
23.

Age differences in affective decision making as indexed by performance on the Iowa Gambling Task.

Cauffman E, Shulman EP, Steinberg L, Claus E, Banich MT, Graham S, Woolard J.

Dev Psychol. 2010 Jan;46(1):193-207. doi: 10.1037/a0016128.

PMID:
20053017
24.

Regulation of vascular endothelial growth factor (VEGF) splicing from pro-angiogenic to anti-angiogenic isoforms: a novel therapeutic strategy for angiogenesis.

Nowak DG, Amin EM, Rennel ES, Hoareau-Aveilla C, Gammons M, Damodoran G, Hagiwara M, Harper SJ, Woolard J, Ladomery MR, Bates DO.

J Biol Chem. 2010 Feb 19;285(8):5532-40. doi: 10.1074/jbc.M109.074930. Epub 2009 Nov 11.

25.

Are adolescents less mature than adults?: minors' access to abortion, the juvenile death penalty, and the alleged APA "flip-flop".

Steinberg L, Cauffman E, Woolard J, Graham S, Banich M.

Am Psychol. 2009 Oct;64(7):583-94. doi: 10.1037/a0014763.

PMID:
19824745
26.

Molecular diversity of VEGF-A as a regulator of its biological activity.

Woolard J, Bevan HS, Harper SJ, Bates DO.

Microcirculation. 2009 Oct;16(7):572-92. doi: 10.1080/10739680902997333. Epub 2009 Jun 1. Review.

27.

Age differences in future orientation and delay discounting.

Steinberg L, Graham S, O'Brien L, Woolard J, Cauffman E, Banich M.

Child Dev. 2009 Jan-Feb;80(1):28-44. doi: 10.1111/j.1467-8624.2008.01244.x. Erratum in: Child Dev. 2010 May;81(3):1024.

PMID:
19236391
28.

Surgery Illustrated--focus on details. Modified posterior reconstruction of the rhabdosphincter: application to robotic-assisted laparoscopic prostatectomy.

Coughlin G, Dangle PP, Patil NN, Palmer KJ, Woolard J, Jensen C, Patel V.

BJU Int. 2008 Nov;102(10):1482-5. doi: 10.1111/j.1464-410X.2008.08090.x. Review. No abstract available.

29.

Age differences in sensation seeking and impulsivity as indexed by behavior and self-report: evidence for a dual systems model.

Steinberg L, Albert D, Cauffman E, Banich M, Graham S, Woolard J.

Dev Psychol. 2008 Nov;44(6):1764-78. doi: 10.1037/a0012955.

PMID:
18999337
30.

Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors.

Nowak DG, Woolard J, Amin EM, Konopatskaya O, Saleem MA, Churchill AJ, Ladomery MR, Harper SJ, Bates DO.

J Cell Sci. 2008 Oct 15;121(Pt 20):3487-95. doi: 10.1242/jcs.016410.

31.

The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice.

Rennel E, Waine E, Guan H, Schüler Y, Leenders W, Woolard J, Sugiono M, Gillatt D, Kleinerman E, Bates D, Harper S.

Br J Cancer. 2008 Apr 8;98(7):1250-7. doi: 10.1038/sj.bjc.6604309. Epub 2008 Mar 18.

32.

Anticipatory injustice among adolescents: age and racial/ethnic differences in perceived unfairness of the justice system.

Woolard JL, Harvell S, Graham S.

Behav Sci Law. 2008;26(2):207-26. doi: 10.1002/bsl.805.

PMID:
18344171
33.

The promise of primary prevention home visiting programs: a review of potential outcomes.

Russell BS, Britner PA, Woolard JL.

J Prev Interv Community. 2007;34(1-2):129-47.

PMID:
17890197
34.

Spontaneous dissection of the celiac artery: a case report.

Woolard JD, Ammar AD.

J Vasc Surg. 2007 Jun;45(6):1256-8.

35.

VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression.

Woolard J, Wang WY, Bevan HS, Qiu Y, Morbidelli L, Pritchard-Jones RO, Cui TG, Sugiono M, Waine E, Perrin R, Foster R, Digby-Bell J, Shields JD, Whittles CE, Mushens RE, Gillatt DA, Ziche M, Harper SJ, Bates DO.

Cancer Res. 2004 Nov 1;64(21):7822-35.

36.

Acute cardiovascular effects of sibutramine in conscious rats.

Woolard J, Bennett T, Dunn WR, Heal DJ, Aspley S, Gardiner SM.

J Pharmacol Exp Ther. 2004 Mar;308(3):1102-10. Epub 2003 Nov 21.

PMID:
14634034
37.

Juveniles' competence to stand trial: a comparison of adolescents' and adults' capacities as trial defendants.

Grisso T, Steinberg L, Woolard J, Cauffman E, Scott E, Graham S, Lexcen F, Reppucci ND, Schwartz R.

Law Hum Behav. 2003 Aug;27(4):333-63.

PMID:
12916225
38.

Persistent lowering of arterial pressure after continuous and intermittent therapy.

Woolard J, Hale TM, Bushfield TL, Adams MA.

J Hypertens. 2003 Apr;21(4):813-20.

PMID:
12658029
39.

Effectiveness of participation as a defendant: the attorney-juvenile client relationship.

Schmidt MG, Reppucci ND, Woolard JL.

Behav Sci Law. 2003;21(2):175-98.

PMID:
12645044
40.

Informing juvenile justice policy: directions for behavioral science research.

Woolard JL, Fondacaro MR, Slobogin C.

Law Hum Behav. 2001 Feb;25(1):13-24. Review.

PMID:
11276858
41.

Social, community, and preventive interventions.

Reppucci ND, Woolard JL, Fried CS.

Annu Rev Psychol. 1999;50:387-418. Review.

PMID:
10074683
42.

Regional wall motion abnormalities after prolonged exercise in the normal left ventricle.

Douglas PS, O'Toole ML, Woolard J.

Circulation. 1990 Dec;82(6):2108-14.

PMID:
2242535

Supplemental Content

Loading ...
Support Center